Van Hulzen Asset Management, LLC Biogen Inc. Transaction History

Van Hulzen Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$258.66 - $342.55 $193,736 - $256,569	-749 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$268.85 - $341.04 $201,368 - $255,438	749 New	749 $237,000
Q1 2019 May 01, 2019	SELL	$216.71 - $338.96 $154,730 - $242,017	-714 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$278.5 - $352.75 $198,849 - $251,863	714 New	714 $215,000

998

130M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Van Hulzen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Van Hulzen Asset Management, LLC with notifications on news.